Sana Biotechnology, Inc. shares surge as a breakthrough in diabetes therapy sparks investor interest. Click for my updated ...

Financial analyst upgrades Allstate, Aon, and Willis Towers Watson stocks, citing growth potential not yet recognized by the ...

GSK (GSK) stock is in focus as the company is nearing a $1B deal to acquire IDRx, a private biotech focused on a rare ...

The key pillar of my bull thesis is the company's ability to complete the $1.66 billion loan from the Department of Energy.

BUI gets positive ratings, DNP CEFs faces strong sell signals. Find out how a 12% distribution hike affects their current ...

Stocks are adjusting to yield curve normalization, not inflation fears. Job openings and ISM Services PMI rise suggest ...

The U.S. Treasury 10-year yield could trend toward 5% in 2025, supported by a combination of historical averages and a ...

US corporate bankruptcy filings hit a 14-year high in 2024 as filings continued at a steady clip in December 2024 and ...

Explore the latest developments in the offshore wind industry, from Orsted's stock declines to strategic partnerships and ...

Walgreens Boots Alliance has seen a significant decline in stock price. Read why I am reaffirming my Hold rating on WBA ahead ...

SPYI is a buy-write ETF from Neos with an 11.9% dividend yield, benefiting from a strong equity rally since its 2022 IPO.

Fed funds futures appear to be pricing in high odds that the central bank will leave its target rate unchanged at a 4.25-4.50 ...